MENU
AMLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Amylyx Pharmaceuticals (AMLX) Earnings Date & Reports

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs... Show more

A.I. Advisor
published Earnings

AMLX is expected to report earnings to fall 2.56% to -37 cents per share on November 05

Amylyx Pharmaceuticals AMLX Stock Earnings Reports
Q3'26
Est.
$-0.38
Q2'26
Missed
by $0.04
Q1'26
Missed
by $0.04
Q4'25
Beat
by $0.04
Q3'25
Beat
by $0.08
The last earnings report on August 06 showed earnings per share of -38 cents, missing the estimate of -34 cents. With 181.99K shares outstanding, the current market capitalization sits at 3.64B.